Cortellis™ accelerates life sciences innovation via trusted intelligence and actionable insights. Our accredited global alliance program delivers value-added solutions by combining Cortellis offerings with those of technology and service providers. Partner with us to fuel profitable growth, increase revenue and deliver greater value to your customers.
Partners can augment their existing offerings with our expertise, intelligence and data science capabilities to expand growth opportunities and drive incremental revenue. Our structured program provides enhanced access to curated content, comprehensive training resources, integration support and joint marketing initiatives – all designed to maximize our combined capabilities.
Access to leading industry intelligence
Flexible licensing terms available.
Tiered partner framework
Provides a path for future growth based on your needs.
Coordinated business development
Lead sharing and joint promotion.
Dedicated partner team
Training, enablement and certification programs.
High-impact, collaborative Marketing programs to customers and prospects.
Help from industry experts plus training materials to empower your team.
Visualizing intellectual property and intelligence solutions for R&D, patenting, business development and licensing.
Applying Clarivate intelligence across discovery and pre-clinical applications.
Delivering actionable toxicity and safety intelligence to life science professionals.
Streamlining regulatory compliance and GxP processes via Gartner-recognized solutions.
Advancing how companies integrate, access and share information.
Providing highly relevant, objective insights based on artificial intelligence (AI)-driven technologies.
Optimizing clinical research through AI-driven quality oversight and trial optimization software.
Solving clients’ data management and analytical challenges using Cortellis intelligence.
We require our partners to be accredited through a multi-step program, which includes following a comprehensive audit of policies and procedures, completing training programs to ensure appropriate use and interpretation of Cortellis intelligence, and successfully demonstrating data and/or application integration (if appropriate). This rigorous process ensures that partners’ offerings are high quality, and that partners can be relied on to provide their offerings to minimize risk and maximize value.
Accelerate research, development and commercialization through Clarivate offerings, or via novel solutions derived from combinations of our unique capabilities and those of our carefully selected partners. Visit our Innovation Exchange to see how.
Clarivate Analytics acquires Decision Resources Group
Clarivate has acquired Decision Resources Group (DRG) to support customers across the entire drug, device and medical technology lifecycle — from research to outcome.
Clarivate Analytics expands global life science alliances program with three new technology partners
New partners enable extended use of Cortellis life science intelligence solutions to help companies accelerate innovation.
Clarivate Analytics introduces next-generation pre-clinical drug research platform with Cortellis Drug Discovery Intelligence
Updated solution enables enhanced analytics and greater utility of biology, chemistry and pharmacology data—within a single application.
New Clarivate Analytics report shows the cost to bring a drug to market has decreased to under $2B for the first time in over five years
Pharmaceutical R&D industry report provides insights into what’s behind decade-high drug approval rates and reveals implications of costs and sustainability.